Evergreen · By Jacob Teague · · Updated

What a PCAC vote does. What it does not.

A committee can recommend. The agency still has to write a rule. A vote is not a license.

PCAC is FDA’s Pharmacy Compounding Advisory Committee. It advises the agency on whether a bulk substance should be added to the 503A Bulks List — the list of ingredients a 503A compounding pharmacy may use when it compounds for an identified patient.

A yes vote is a recommendation. It does not put the substance on the list. FDA still needs notice-and-comment rulemaking: a proposed rule, public comment, a final rule. FDA is not required to follow the committee.

It is also not drug approval. Approval is a different process, for a specific product, after the sponsor files. A compounded preparation is not that product. See three kinds of peptides.

On July 23–24, 2026, PCAC recommended six peptides for the 503A Bulks List and voted against one. That meeting is the news piece. This page is the ladder: vote ≠ list ≠ license ≠ approval.

A committee raising its hands did not change the law. In October 2026, HHS took a separate step: an enforcement discretion policy. That is a statement about enforcement, not a rule, a listing or an approval.

Update, November 11, 2026. On October 30, 2026, HHS published a draft enforcement discretion policy for compounding certain peptides. It says HHS does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician that compounds with a peptide on its list while the 503A Bulks List is developed through rulemaking. Law-firm summaries of the policy list the same six peptides the committee backed (BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500) and ten conditions, including a valid patient-specific prescription. Outsourcing facilities are not covered. The policy does not approve any peptide, does not add any peptide to the Bulks List, and is not binding. HHS says it may revisit it if a safety or quality problem arises. Comments were due November 13, 2026. None of these peptides is an FDA-approved drug.

Citations

Peptide Vault is a personal log and research library. Not medical advice, not a pharmacy, not a shop. We do not tell you what to take or where to get it. No dosing. No where-to-buy. No mix tutorials. No heal/optimize claims.

Optional

Peptide brief

Weekly. What changed. What isn’t approved.

Optional. Weekly if we send it. Not a protocol.